Regulations: health_claims

UK MHRA Human Medicines Regulations

UK law bars advertising prescription-only medicines to the public and requires medicine ads to stay on-licence, with required content for OTC ads.

Italian Pharmaceutical Advertising

Italy bans public advertising of prescription medicines and requires consumer ads for non-prescription medicines to carry minimum information, a leaflet invitation and Ministry of Health authorization.

AK OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Alaska consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

AL OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Alabama consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

AR OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Arkansas consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

AZ OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Arizona consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

German Medical Device Marketing

German medical device ads must not mislead about efficacy or certification, promise success, or use misleading testimonials.

CA OTC Drug Marketing - Board of Pharmacy

California's Sherman Law bars false or misleading drug advertising; OTC drug ads must stay within the product's labeled OTC uses and must not overstate efficacy or regulatory status.

CA Medical Advertising

California healing-arts ads must not be false or misleading, create unjustified expectations of results, use altered images, or misstate fees or board certification.

Health Canada Medical Device Advertising

Canadian medical device ads must stay within the licensed indication, not be misleading, and not promote treatment, prevention or cure of Schedule A.1 diseases to the public.

Alabama Medical Cannabis Marketing Standards

Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Arkansas Medical Cannabis Marketing Standards

Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Wisconsin CBD-Only Program

Wisconsin's Lydia's Law only protects possession of CBD oil with physician certification; hemp CBD may be sold within federal and state hemp THC limits, but ads may not claim state medical authorization or disease benefits.

Hawaii Medical Cannabis Marketing Standards

Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Iowa Medical Cannabis Marketing Standards

Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Kentucky Medical Cannabis Marketing Standards

Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Louisiana Medical Cannabis Marketing Standards

Louisiana's medical cannabis program (Louisiana Department of Health — Medical Marijuana Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

New Hampshire Medical Cannabis Marketing Standards

New Hampshire's medical cannabis program (New Hampshire Department of Health and Human Services — Therapeutic Cannabis Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

North Dakota Medical Cannabis Marketing Standards

North Dakota's medical cannabis program (North Dakota Department of Health and Human Services — Medical Marijuana Division) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Oklahoma Medical Cannabis Marketing Standards

Oklahoma's medical cannabis program (Oklahoma Medical Marijuana Authority (OMMA)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Pennsylvania Medical Cannabis Marketing Standards

Pennsylvania's medical cannabis program (Pennsylvania Department of Health — Office of Medical Marijuana) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

South Dakota Medical Cannabis Marketing Standards

South Dakota's medical cannabis program (South Dakota Department of Health — Medical Cannabis Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Utah Medical Cannabis Marketing Standards

Utah's medical cannabis program (Utah Department of Health and Human Services — Center for Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.

Telehealth Marketing

Telehealth ads must not overstate what virtual care can do, guarantee prescriptions or outcomes, or imply Medicare or government endorsement.

CO OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Colorado consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

DE OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

Dutch Healthcare Advertising

Dutch healthcare provider ads must not guarantee outcomes, make unsupported superlative claims, or present individual results or prices misleadingly.

EU EMA Medicinal Products Advertising

Advertising prescription-only medicines to the EU general public is prohibited; unbranded disease awareness and materials for health professionals are allowed.

EU Food Supplements Directive

EU food supplement marketing must not make medicinal claims, may use only authorised health claims, and labels and listings must carry the mandatory daily-dose, warning and varied-diet statements.

EU Medical Device Marketing

MDR Art. 7 bars device advertising that misleads about intended purpose, safety or performance, for example by ascribing functions the device lacks or suggesting uses outside its intended purpose.

EU Medicinal Product Advertising

Public advertising of non-prescription medicines in the EU must identify the ad and the medicine, name it, invite the reader to read the leaflet, and avoid the prohibited claims in Art. 90.

FDA Antidandruff Monograph Compliance

Limits dandruff, seborrheic dermatitis and psoriasis claims to those the OTC monograph permits for the product's active ingredient, and bars cure or permanence claims.

FDA Antiperspirant Monograph Compliance

Limits antiperspirant claims to monograph-permitted wetness claims, bars sweat claims for deodorants without an active, and requires the kidney-disease warning on labels.

FDA Dietary Supplement Claims

Bars supplement marketing that implies a disease effect through product names, images, testimonials, cited publications or disease symptoms.

FDA Drug Definition Standards

Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.

FDA External Drug Products

OTC external drug products covered by 21 CFR 358 (warts, corns and calluses, ingrown toenails, lice, dandruff, seborrheic dermatitis, psoriasis) may only claim the uses and actives in their monograph.

FDA Food Labeling - Health Claims (21 CFR 101.14)

Food and supplement labels may link a substance to reduced disease risk only through FDA-authorized or qualified health claims, in the required form, and only on foods meeting nutrient eligibility; disease treatment claims are not allowed.

FDA Homeopathic Drug Products

Homeopathic products are drugs; marketing must not imply FDA approval, must not promote them for serious diseases, and efficacy claims must be scientifically supported or clearly qualified as based only on homeopathic theory.

FDA Infant Formula & Baby Food Advertising

Infant formula and baby food marketing must not be misleading, including claims of equivalence to breast milk, disease prevention, guaranteed development or absolute contaminant-free status; formulas must meet FDA nutrient and notification requirements.

FDA Medical Device Advertising and Promotion

Device promotion must describe FDA status accurately (cleared, approved or De Novo authorized), must not imply approval from registration, must not promote investigational devices, and restricted-device ads need a brief risk statement.

FDA SaMD Marketing

SaMD marketing must use the correct FDA status term (approved only for PMA devices, cleared for 510(k)), must not imply FDA endorsement or treat registration as approval, and must not claim uses beyond the authorized intended use.

FDA Sports Nutrition DSHEA Compliance

Sports supplements may make structure/function claims only with the full FDA disclaimer on labeling and must not make disease or drug-equivalent claims.

FDA Sunscreen Monograph Compliance

Sunscreen marketing must use monograph-consistent claims: no 'sunblock', 'waterproof', 'sweatproof', instant or all-day protection claims, water resistance only as 40 or 80 minutes, and broad-spectrum and skin-cancer claims only for qualifying products.

FDA Telehealth & Online Pharmacy Advertising

Telehealth and online pharmacy ads must not claim or imply that compounded drugs are FDA-approved, generic or equivalent to branded drugs, or proven safe and effective, and ads making drug benefit claims must include risk information.

FDA OPDP Help-Seeking / Disease Awareness Ads

Disease-awareness ads from drug firms may discuss a condition and urge a doctor visit but must not name, cue or point to a specific drug; if they do, they become product ads needing risk information.

FDA OPDP Off-Label Promotion Prohibition

Drug firms may not promote prescription drugs for unapproved uses; scientific information on unapproved uses may go to HCPs only if separate from promotion and accompanied by the disclosures in FDA's 2025 guidance.

FL OTC Drug Marketing - Board of Pharmacy

Florida's Drug and Cosmetic Act bars false or misleading drug advertising; OTC drug ads must stay within labeled uses and accurately state strength and regulatory status.

FL Healthcare Professional Advertising

Florida physician and practitioner ads must not be false, deceptive or misleading, including unsupported success rates, guarantees and specialty claims.

FTC Dietary Supplement Substantiation

Supplement marketing may not make disease or FDA-approval claims, health claims need competent and reliable scientific evidence, and labeling with structure/function claims must carry the FDA disclaimer.

FTC Food Advertising - Health and Nutrition Claims

The FTC requires food and beverage health and nutrition advertising claims to be truthful, not misleading and backed by competent and reliable scientific evidence, applying FDA labeling definitions as a benchmark.

FTC Health Product Compliance Guidance

Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease.

FTC Homeopathic - Efficacy Disclosure Requirements

Ads for OTC homeopathic drugs that make efficacy claims must convey that there is no scientific evidence the product works and that the claims rest only on 1700s homeopathic theories most modern experts reject.

FTC Sexual Wellness Advertising Standards

Sexual wellness advertising must be truthful and substantiated: non-drug products may not claim to treat sexual disorders or match prescription drugs, and enlargement, performance and safety claims must not be deceptive.

GA OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Georgia consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

Canada Health Product Advertising

In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.

Canadian Medical Device Advertising

Canadian medical device ads must not make treatment or cure claims for Schedule A.1 diseases to the public, misrepresent Health Canada authorization, or make false or misleading claims.

Health Canada Digital Therapeutics Advertising

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.

HI OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Hawaii consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

IA OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Iowa consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

ID OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Idaho consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

IL OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Illinois consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

IN OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Indiana consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

KS OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Kansas consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

KY OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Kentucky consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

LA OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Louisiana consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

MA OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Massachusetts consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

MD OTC Drug Marketing - State Board of Pharmacy

Maryland and federal law bar false or misleading OTC drug advertising; ads must not claim cures, FDA approval or prescription strength, or make absolute safety claims beyond the product's labeled uses.

ME OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Maine consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

Meta CPG Health Claims Restrictions

Meta CPG and supplement ads must not make disease-treatment, guaranteed-outcome or disease-framed detox or immunity claims; ordinary structure/function claims are allowed.

MN OTC Drug Marketing - Board of Pharmacy ALT

OTC drug ads directed to Minnesota consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

MO OTC Drug Marketing - Board of Pharmacy ALT

OTC drug ads directed to Missouri consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

MT OTC Drug Marketing - Board of Pharmacy

OTC drug ads directed to Montana consumers must not make false or misleading use, efficacy or safety claims or promote uses outside the label; Drug Facts content is checked only on packaging and labels.

NC OTC Drug Marketing - Board of Pharmacy

OTC drug ads seen by North Carolina consumers must make only truthful, substantiated claims within labeled OTC indications; Drug Facts, warnings and directions are checked only on packaging and labeling.

NH OTC Drug Marketing - Board of Pharmacy

OTC drug ads seen by New Hampshire consumers must make only truthful, substantiated claims within labeled OTC indications; Drug Facts, warnings and directions are checked only on packaging and labeling.

NM OTC Drug Marketing - Board of Pharmacy

OTC drug ads seen by New Mexico consumers must make only truthful, substantiated claims within labeled OTC indications; Drug Facts, warnings and directions are checked only on packaging and labeling.

NC Healthcare Provider Advertising

North Carolina physician ads must not be false, deceptive or unsubstantiated, including guarantees, unsupported success rates and inaccurate board-certification claims.

NV OTC Drug Marketing - State Board of Pharmacy

Nevada and federal law bar false or misleading OTC drug ads; claims must stay within labeled uses without cure, universal-age safety or absolute claims, and packaging must carry Drug Facts.

OH Healthcare Professional Advertising

Ohio physician ads must not contain false, fraudulent, deceptive or misleading statements, including unjustified expectations of results and unsupported outcome claims.

PA Medical Advertising

Pennsylvania physician and clinic ads must not make false, deceptive or misleading claims about outcomes, safety, credentials or superiority.

RI OTC Drug Marketing - Board of Pharmacy

OTC drug ads seen by Rhode Island consumers must make only truthful, substantiated claims within labeled OTC indications; Drug Facts, warnings and directions are checked only on packaging and labeling.

SC OTC Drug Marketing - Board of Pharmacy

OTC drug ads seen by South Carolina consumers must make only truthful, substantiated claims within labeled OTC indications; Drug Facts, warnings and directions are checked only on packaging and labeling.

Alaska Pharmacy Advertising and Marketing Standards

Alaska's pharmacy practice law, enforced by the Alaska Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Alaska pharmacy ads.

Arizona Pharmacy Advertising and Marketing Standards

Arizona's pharmacy practice law, enforced by the Arizona State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Arizona pharmacy ads.

California Pharmacy Advertising and Marketing Standards

California's pharmacy practice law, enforced by the California State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in California pharmacy ads.

Colorado Pharmacy Advertising and Marketing Standards

Colorado's pharmacy practice law, enforced by the Colorado State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Colorado pharmacy ads.

Connecticut Pharmacy Advertising and Marketing Standards

Connecticut pharmacy ads must not misstate drug efficacy or safety, call compounded drugs FDA-approved, make unqualified price claims, offer Rx incentives without federal program exclusions, or offer Rx drugs without a prescription.

Florida Pharmacy Advertising and Marketing Standards

Florida's pharmacy practice law, enforced by the Florida Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Florida pharmacy ads.

Georgia Pharmacy Advertising and Marketing Standards

Georgia's pharmacy practice law, enforced by the Georgia Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Georgia pharmacy ads.

Hawaii Pharmacy Advertising and Marketing Standards

Hawaii's pharmacy practice law, enforced by the Hawaii Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Hawaii pharmacy ads.

Idaho Pharmacy Advertising and Marketing Standards

Idaho's pharmacy practice law, enforced by the Idaho Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Idaho pharmacy ads.

Illinois Pharmacy Advertising and Marketing Standards

Illinois pharmacy ads must not misstate drug efficacy or safety, call compounded drugs FDA-approved, make unqualified price claims, offer Rx incentives without federal program exclusions, or offer Rx drugs without a prescription.

Indiana Pharmacy Advertising and Marketing Standards

Indiana's pharmacy practice law, enforced by the Indiana State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Indiana pharmacy ads.

Iowa Pharmacy Advertising and Marketing Standards

Iowa's pharmacy practice law, enforced by the Iowa Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Iowa pharmacy ads.

Kansas Pharmacy Advertising and Marketing Standards

Kansas's pharmacy practice law, enforced by the Kansas State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Kansas pharmacy ads.

Kentucky Pharmacy Advertising and Marketing Standards

Kentucky's pharmacy practice law, enforced by the Kentucky Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Kentucky pharmacy ads.

Louisiana Pharmacy Advertising and Marketing Standards

Louisiana's pharmacy practice law, enforced by the Louisiana Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Louisiana pharmacy ads.

Maine Pharmacy Advertising and Marketing Standards

Maine's pharmacy practice law, enforced by the Maine Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Maine pharmacy ads.

Maryland Pharmacy Advertising and Marketing Standards

Maryland's pharmacy practice law, enforced by the Maryland Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Maryland pharmacy ads.

Michigan Pharmacy Advertising and Marketing Standards

Michigan's pharmacy practice law, enforced by the Michigan Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Michigan pharmacy ads.

Minnesota Pharmacy Advertising and Marketing Standards

Minnesota's pharmacy practice law, enforced by the Minnesota Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Minnesota pharmacy ads.

Mississippi Pharmacy Advertising and Marketing Standards

Mississippi's pharmacy practice law, enforced by the Mississippi Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Mississippi pharmacy ads.

Missouri Pharmacy Advertising and Marketing Standards

Missouri's pharmacy practice law, enforced by the Missouri State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Missouri pharmacy ads.

Montana Pharmacy Advertising and Marketing Standards

Montana's pharmacy practice law, enforced by the Montana Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Montana pharmacy ads.

Nebraska Pharmacy Advertising and Marketing Standards

Nebraska's pharmacy practice law, enforced by the Nebraska Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Nebraska pharmacy ads.

Nevada Pharmacy Advertising and Marketing Standards

Nevada's pharmacy practice law, enforced by the Nevada State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Nevada pharmacy ads.

New Hampshire Pharmacy Advertising and Marketing Standards

New Hampshire's pharmacy practice law, enforced by the New Hampshire Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in New Hampshire pharmacy ads.

New Jersey Pharmacy Advertising and Marketing Standards

New Jersey's pharmacy practice law, enforced by the New Jersey Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in New Jersey pharmacy ads.

New Mexico Pharmacy Advertising and Marketing Standards

New Mexico's pharmacy practice law, enforced by the New Mexico Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in New Mexico pharmacy ads.

New York Pharmacy Advertising and Marketing Standards

New York's pharmacy practice law, enforced by the New York State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in New York pharmacy ads.

North Carolina Pharmacy Advertising and Marketing Standards

North Carolina's pharmacy practice law, enforced by the North Carolina Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in North Carolina pharmacy ads.

North Dakota Pharmacy Advertising and Marketing Standards

North Dakota's pharmacy practice law, enforced by the North Dakota State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in North Dakota pharmacy ads.

Ohio Pharmacy Advertising and Marketing Standards

Ohio's pharmacy practice law, enforced by the Ohio State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Ohio pharmacy ads.

Oklahoma Pharmacy Advertising and Marketing Standards

Oklahoma's pharmacy practice law, enforced by the Oklahoma State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Oklahoma pharmacy ads.

Oregon Pharmacy Advertising and Marketing Standards

Oregon's pharmacy practice law, enforced by the Oregon State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Oregon pharmacy ads.

Pennsylvania Pharmacy Advertising and Marketing Standards

Pennsylvania's pharmacy practice law, enforced by the Pennsylvania State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Pennsylvania pharmacy ads.

Rhode Island Pharmacy Advertising and Marketing Standards

Rhode Island's pharmacy practice law, enforced by the Rhode Island Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Rhode Island pharmacy ads.

South Carolina Pharmacy Advertising and Marketing Standards

South Carolina's pharmacy practice law, enforced by the South Carolina Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in South Carolina pharmacy ads.

South Dakota Pharmacy Advertising and Marketing Standards

South Dakota's pharmacy practice law, enforced by the South Dakota Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in South Dakota pharmacy ads.

Tennessee Pharmacy Advertising and Marketing Standards

Tennessee's pharmacy practice law, enforced by the Tennessee Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Tennessee pharmacy ads.

Texas Pharmacy Advertising and Marketing Standards

Texas's pharmacy practice law, enforced by the Texas State Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Texas pharmacy ads.

Vermont Pharmacy Advertising and Marketing Standards

Vermont's pharmacy practice law, enforced by the Vermont Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Vermont pharmacy ads.

Virginia Pharmacy Advertising and Marketing Standards

Virginia's pharmacy practice law, enforced by the Virginia Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in Virginia pharmacy ads.

West Virginia Pharmacy Advertising and Marketing Standards

West Virginia's pharmacy practice law, enforced by the West Virginia Board of Pharmacy, bars false or misleading pharmacy advertising; the rule checks visible compounding, prescription-access, incentive, price and efficacy claims. No license-number or pharmacy-type statement is required in West Virginia pharmacy ads.

TX Healthcare Advertising

Texas physician ads must not be false, misleading or deceptive about outcomes, credentials or specialties, and board-certification claims must meet 22 TAC 164.4.

TX Food Labeling & Health Claims

Texas food and beverage marketing must use nutrient content and health claims that meet federal definitions adopted by Texas and must not claim to cure or prevent disease.

TX OTC Drug Marketing - State Board of Pharmacy

Texas and federal law bar false or misleading OTC drug ads, including disease claims, misstated ingredients, prescription-superiority claims and blanket child-safety claims; packaging must carry Drug Facts.

GMC Medical Practitioner Advertising

UK doctors must keep information about their services factual and verifiable, avoid guarantees and pressure offers, and give balanced risk information.

U.K. Medical Device Advertising

UK medical device ads must not misstate the device's regulatory status (for example 'MHRA approved'), promote uses outside its intended purpose, guarantee results or make unsupported efficacy claims.

UK Medicinal Product Advertising

UK law bans advertising prescription-only medicines to the public and requires all medicine ads to match the product's authorisation, with label-reading invitations on consumer OTC ads.

UK MHRA AI as Software as Medical Device (SaMD)

UK marketing of software or AI tools with medical-purpose claims must be consistent with their medical-device status, must not claim MHRA approval and must substantiate performance claims.

VA OTC Drug Marketing - Board of Pharmacy

OTC drug advertising and labeling for Virginia consumers must stay within approved labeling and avoid false or unsubstantiated efficacy, safety and comparative claims.

WV Accident and Health Insurance

West Virginia accident and sickness insurance ads must label limited-benefit products accurately, disclose exclusions and limitations with benefit descriptions and identify the insurer.

WY Cancer Insurance Ad

Wyoming cancer and critical illness insurance ads must state that benefits are limited and supplemental, disclose key limitations and avoid exaggerated fear appeals or statistics.

Get a free homepage compliance scan